Search research articles
Contact Us
Filters
Showing results (51-60 of 106) with videos related to
Page
of 11
Sort By:
Oncotarget
|
November 9, 2017
Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
Zhen Qu, Junhua Wu, Junyi Wu, et al.
Medcomm
|
September 12, 2025
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities
Yuxin Zhang, Nan Wang, Louqian Zhang, et al.
Optics Letters
|
March 1, 2024
Governance of Friedrich-Wintgen bound states in the continuum by tuning the internal coupling of meta-atoms
Peiliang Liu, Zhenyu Zhao, Yonghui Xue, et al.
Cell & Bioscience
|
October 12, 2023
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Journal of Cellular Physiology
|
August 13, 2025
Mitochondrial Pyruvate Carrier Differentially Controls the Self-Renewal and Differentiation of Human Pluripotent Stem Cells
Dacheng Jiang, Yuchen Wang, Yanhao Chen, et al.
Experimental Hematology & Oncology
|
July 3, 2026
Leveraging multimodal cancer immunotherapy to amplify the efficacy of oncolytic viruses
Qiying Cai, Louqian Zhang, Lingkai Kong, et al.
The International Journal of Biochemistry & Cell Biology
|
May 26, 2019
Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy
Guang Zhang, Zhongxia Wang, Weibo Chen, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
August 23, 2017
Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation
Song Liu, Ji Miao, Xiaolei Shi, et al.
Frontiers in Oncology
|
July 17, 2020
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
Weiwei Shi, Shan Zhang, Ding Ma, et al.
Cancer Medicine
|
August 11, 2023
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Junyi Wu, Xiangjie Xu, Shasha Wu, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 106) with videos related to
Sort By:
Page
of 11
Oncotarget
|
November 9, 2017
Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
Zhen Qu, Junhua Wu, Junyi Wu, et al.
Medcomm
|
September 12, 2025
Serotonin (5-Hydroxytryptamine): Metabolism, Signaling, Biological Functions, Diseases, and Emerging Therapeutic Opportunities
Yuxin Zhang, Nan Wang, Louqian Zhang, et al.
Optics Letters
|
March 1, 2024
Governance of Friedrich-Wintgen bound states in the continuum by tuning the internal coupling of meta-atoms
Peiliang Liu, Zhenyu Zhao, Yonghui Xue, et al.
Cell & Bioscience
|
October 12, 2023
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies
Ciliang Guo, Lingkai Kong, Lingjun Xiao, et al.
Journal of Cellular Physiology
|
August 13, 2025
Mitochondrial Pyruvate Carrier Differentially Controls the Self-Renewal and Differentiation of Human Pluripotent Stem Cells
Dacheng Jiang, Yuchen Wang, Yanhao Chen, et al.
Experimental Hematology & Oncology
|
July 3, 2026
Leveraging multimodal cancer immunotherapy to amplify the efficacy of oncolytic viruses
Qiying Cai, Louqian Zhang, Lingkai Kong, et al.
The International Journal of Biochemistry & Cell Biology
|
May 26, 2019
Dual effects of gossypol on human hepatocellular carcinoma via endoplasmic reticulum stress and autophagy
Guang Zhang, Zhongxia Wang, Weibo Chen, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research
|
August 23, 2017
Risk Factors for Post-Transplant Death in Donation after Circulatory Death Liver Transplantation
Song Liu, Ji Miao, Xiaolei Shi, et al.
Frontiers in Oncology
|
July 17, 2020
Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma
Weiwei Shi, Shan Zhang, Ding Ma, et al.
Cancer Medicine
|
August 11, 2023
UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma
Junyi Wu, Xiangjie Xu, Shasha Wu, et al.
Page
of 11